Dáil debates

Tuesday, 14 June 2016

Ceisteanna - Questions

Cabinet Committees

4:15 pm

Photo of Enda KennyEnda Kenny (Mayo, Fine Gael) | Oireachtas source

I confirm that this morning the Government decided not to oppose the parole Bill proposed by Deputy Jim O'Callaghan. The Bill has quite some merit and while there may be issues the Government and the Minister will discuss, the Government will not oppose it.

If the independent Policing Authority requires further powers or instruments, I am sure the Government will want to see to it that it can do its job completely independently. The authority has set its standard already in this regard. It has been very clear on where it sees the path ahead and has had engagement with the Garda Commissioner. I am sure that if the chairperson and members of the authority find that their powers are restricted in some way, the Minister, on behalf of the Government, will be happy to engage with it.

Deputy Micheál Martin asked about the delay in introducing legislation to amend the Misuse of Drugs Act. On 31 May the Minister for Justice and Equality briefed the Government on measures to tackle organised crime in the north inner city and elsewhere. At the meeting the Minister for Health offered to expedite the Misuse of Drugs (Amendment) Bill which had originally been scheduled to be introduced in the autumn of 2016. The Bill was being prepared on the basis of Government decisions resulting from the so-called Bederev challenge to section 2 of the Misuse of Drugs Act 1977 and Statutory Instrument No. 180/2010 and 2042 of 15 December 2015 on the establishment of supervised injecting facilities for chronic drug users. The Minister decided to truncate and bring forward a shortened version of the Bill, which will deal with a range of drugs, namely, Z-drugs and so-called "Clockwork Orange" substances. I also have a list of names that are difficult to pronounce, including hallucinogenic drugs, zopiclone, zaleplon, lizdexamfetamine and phenazapam, all of which are being dealt with.

Comments

No comments

Log in or join to post a public comment.